| Type IV Pili in Francisella tularensis: Roles of pilF and pilT in Fiber Assembly, Host Cell Adherence, and Virulence S Chakraborty, M Monfett, TM Maier, JL Benach, DW Frank, DG Thanassi Infection and immunity 76 (7), 2852-2861, 2008 | 124 | 2008 |
| Concomitant Infection of EnterotoxigenicEscherichia coli in an Outbreak of Cholera Caused byVibrio cholerae O1 and O139 in Ahmedabad, India S Chakraborty, JS Deokule, P Garg, SK Bhattacharya, RK Nandy, GB Nair, ... Journal of clinical microbiology 39 (9), 3241-3246, 2001 | 108 | 2001 |
| The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease MJ Darsley, S Chakraborty, B DeNearing, DA Sack, A Feller, C Buchwaldt, ... Clinical and vaccine immunology 19 (12), 1921-1931, 2012 | 99 | 2012 |
| Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines C Harro, S Chakraborty, A Feller, B DeNearing, A Cage, M Ram, ... Clinical and Vaccine Immunology 18 (10), 1719-1727, 2011 | 95 | 2011 |
| Enterotoxigenic E. coli virulence gene regulation in human infections AA Crofts, SM Giovanetti, EJ Rubin, FM Poly, RL Gutiérrez, KR Talaat, ... Proceedings of the National Academy of Sciences 115 (38), E8968-E8976, 2018 | 81 | 2018 |
| Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment M Pop, JN Paulson, S Chakraborty, I Astrovskaya, BR Lindsay, S Li, ... BMC genomics 17, 1-11, 2016 | 76 | 2016 |
| Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge C Harro, AL Bourgeois, D Sack, R Walker, B DeNearing, J Brubaker, ... Vaccine 37 (14), 1978-1986, 2019 | 75 | 2019 |
| Diagnostic techniques for rapid detection of Vibrio cholerae O1/O139 T Ramamurthy, B Das, S Chakraborty, AK Mukhopadhyay, DA Sack Vaccine 38, A73-A82, 2020 | 74 | 2020 |
| A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is … C Harro, D Sack, AL Bourgeois, R Walker, B DeNearing, A Feller, ... Clinical and Vaccine Immunology 18 (12), 2118-2127, 2011 | 72 | 2011 |
| Association of Cytolethal Distending Toxin Locus cdtB with Enteropathogenic Escherichia coli Isolated from Patients with Acute Diarrhea in Calcutta, India M Pandey, A Khan, SC Das, B Sarkar, S Kahali, S Chakraborty, ... Journal of clinical microbiology 41 (11), 5277-5281, 2003 | 69 | 2003 |
| Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection KR Talaat, C Alaimo, P Martin, AL Bourgeois, AM Dreyer, RW Kaminski, ... EBioMedicine 66, 2021 | 67 | 2021 |
| Characterization of the Francisella tularensis subsp. novicida type IV pilus X Zogaj, S Chakraborty, J Liu, DG Thanassi, KE Klose Microbiology 154 (7), 2139-2150, 2008 | 60 | 2008 |
| Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity P Kumar, FM Kuhlmann, S Chakraborty, AL Bourgeois, J Foulke-Abel, ... The Journal of clinical investigation 128 (8), 3298-3311, 2018 | 56 | 2018 |
| Occurrence of Hybrid Escherichia coli Strains Carrying Shiga Toxin and Heat-Stable Toxin in Livestock of Bangladesh FT Johura, R Parveen, A Islam, A Sadique, MN Rahim, S Monira, ... Frontiers in public health 4, 287, 2017 | 55 | 2017 |
| Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development S Chakraborty, A Randall, TJ Vickers, D Molina, CD Harro, B DeNearing, ... The Journal of infectious diseases 218 (9), 1436-1446, 2018 | 51 | 2018 |
| Identification of a family of Bsp-A like surface proteins of Entamoeba histolytica with novel leucine rich repeats PH Davis, Z Zhang, M Chen, X Zhang, S Chakraborty, SL Stanley Jr Molecular and biochemical parasitology 145 (1), 111, 2005 | 49 | 2005 |
| Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC … J Brubaker, X Zhang, AL Bourgeois, C Harro, DA Sack, S Chakraborty Gut Microbes 13 (1), 1891852, 2021 | 45 | 2021 |
| Evaluation of the safety, tolerability, and immunogenicity of an oral, inactivated whole-cell Shigella flexneri 2a vaccine in healthy adult subjects S Chakraborty, C Harro, B DeNearing, J Bream, N Bauers, L Dally, ... Clinical and Vaccine Immunology 23 (4), 315-325, 2016 | 45 | 2016 |
| Characterization of mucosal immune responses to enterotoxigenic Escherichia coli vaccine antigens in a human challenge model: response profiles after primary infection and … S Chakraborty, C Harro, B DeNearing, M Ram, A Feller, A Cage, ... Clinical and Vaccine Immunology 23 (1), 55-64, 2016 | 45 | 2016 |
| An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli CK Porter, MS Riddle, AN Alcala, DA Sack, C Harro, S Chakraborty, ... PloS one 11 (3), e0149358, 2016 | 39 | 2016 |
